<p>BALB/c mice (n = 5) were immunized once subcutaneously with 1, 5, or 20 µg of LcED III. (A) Seroconversion rates and (B) the optical density of serum samples at a 2500-fold dilution versus time after immunization are plotted. (C) Sera samples were collected four weeks after the immunization. The neutralizing antibody titer of the sera in each mouse was determined by FRNT. (D) Immunized mice were challenged intraperitoneally with 5×10<sup>6</sup> FFU of live dengue-2 virus at week 28 post-priming. Sera obtained from naïve mice inoculated with live dengue-2 virus served as controls. Serum samples were collected in each mouse to evaluate neutralization of the infectivity of dengue virus by FRNT. The neutralizing antibody titer was calculate...
<p>(A) 51–65, (B) 71–90, (C) 131–170, (D) 196–210 and (E) 246–260 identified in naturally dengue-inf...
Non-neutralizing, serotype-specific anti-NS1 monoclonal antibodies partially protected passively imm...
Background: Dengue is a global arboviral threat to humans; causing 390 million infections per year. ...
<p>BALB/c mice (n = 5) were immunized subcutaneously with 20 µg of cED III or LcED III two times at ...
1<p>Groups of BALB/c mice (n = 5) were immunized three times subcutaneously with 3, 10, or 30 µg of ...
1<p>Mice were immunized with D1ED III (10 µg/dose) formulated with the indicated adjuvants three tim...
<p>Groups of BALB/c mice (n = 5) were immunized subcutaneously with 10 µg D2ED III or LD2ED III two ...
<p>BALB/c mice were immunized subcutaneously with 20 µg of cED III or LcED III two times at a two-we...
<p>Groups of BALB/c mice (n = 5) were immunized subcutaneously with 10 µg D2ED III or LD2ED III two ...
To protect against dengue viral infection, a novel lipidated dengue subunit vaccine was rationally d...
[[abstract]]To protect against dengue viral infection, a novel lipidated dengue subunit vaccine was ...
[[abstract]]A novel dengue vaccine candidate comprised of a consensus dengue virus envelope protein ...
Abstract. A dengue-2 (DEN-2) DNA vaccine coding for the premembrane and envelope (E) proteins and a ...
DNA vaccine against dengue is an interesting strategy for a prime/boost approach. This study evaluat...
<p>Groups of 6- to 8-week-old BALB/c female mice (n = 6) were immunized three times at 2-week interv...
<p>(A) 51–65, (B) 71–90, (C) 131–170, (D) 196–210 and (E) 246–260 identified in naturally dengue-inf...
Non-neutralizing, serotype-specific anti-NS1 monoclonal antibodies partially protected passively imm...
Background: Dengue is a global arboviral threat to humans; causing 390 million infections per year. ...
<p>BALB/c mice (n = 5) were immunized subcutaneously with 20 µg of cED III or LcED III two times at ...
1<p>Groups of BALB/c mice (n = 5) were immunized three times subcutaneously with 3, 10, or 30 µg of ...
1<p>Mice were immunized with D1ED III (10 µg/dose) formulated with the indicated adjuvants three tim...
<p>Groups of BALB/c mice (n = 5) were immunized subcutaneously with 10 µg D2ED III or LD2ED III two ...
<p>BALB/c mice were immunized subcutaneously with 20 µg of cED III or LcED III two times at a two-we...
<p>Groups of BALB/c mice (n = 5) were immunized subcutaneously with 10 µg D2ED III or LD2ED III two ...
To protect against dengue viral infection, a novel lipidated dengue subunit vaccine was rationally d...
[[abstract]]To protect against dengue viral infection, a novel lipidated dengue subunit vaccine was ...
[[abstract]]A novel dengue vaccine candidate comprised of a consensus dengue virus envelope protein ...
Abstract. A dengue-2 (DEN-2) DNA vaccine coding for the premembrane and envelope (E) proteins and a ...
DNA vaccine against dengue is an interesting strategy for a prime/boost approach. This study evaluat...
<p>Groups of 6- to 8-week-old BALB/c female mice (n = 6) were immunized three times at 2-week interv...
<p>(A) 51–65, (B) 71–90, (C) 131–170, (D) 196–210 and (E) 246–260 identified in naturally dengue-inf...
Non-neutralizing, serotype-specific anti-NS1 monoclonal antibodies partially protected passively imm...
Background: Dengue is a global arboviral threat to humans; causing 390 million infections per year. ...